WebNov 28, 2024 · Healthcare-focused private equity firm InvAscent has struck its third new deal this year by investing $15 million (Rs 123 crore) in Mumbai-based pharmaceutical company Sunways India Pvt Ltd. InvAscent invested in the company via its India Life Sciences Fund III (ILSF III) and picked up a minority stake. WebMalladi Drugs & Pharmaceuticals Ltd. We are very competitive in the range of Products & Services that we offer; but more importantly, what sets us apart, are the relationships that …
InvAscent invests Rs 250 cr in Malladi Drugs - MSN
WebAizant is an integrated provider of drug development services with distinctive capabilities in Finished Dosage Formulations and a proprietary portfolio of specialty generics. Offers comprehensive formulation development solutions for … WebMalladi Drugs and Pharmaceuticals Limited. Apr 2010 - Oct 202412 years 7 months. Joined Malladi as Assistant Production Manager and has worked in all their plants at various locations. Elevated through various positions and is currently working as General Manager (Corporate). Involved in many new projects, plant revampings, upgradations, cost ... india\u0027s tibet policy upsc
How InvAscent valued Malladi Drugs in new PE deal after …
WebInvAscent invests Rs 250 cr in bulk drugs firm Malladi Healthcare focused private equity firm InvAscent has invested Rs 250 crore in bulk drugs maker Malladi Drugs and Pharmaceuticals Ltd ...... 25 April Joseph Rai < Prev 1 2 3 4 Next > Web- Raised $ 32 mn for Malladi Drugs and Pharmaceuticals from Invascent - Raised $ 7 mn for Anderson Diagnostics from Tata Healthcare… http://www.malladi.co.in/default.htm india\u0027s third highest civilian award